1) Beard SM, Roskell N, Le TK, et al : Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States. J Med Econ 14: 463-467, 2011 (Epub ahead of print)
3) Finckh A, Bansback N, Marra CA, et al : Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents : a cost-effectiveness analysis. Ann Intern Med 151 : 612-621, 2009
5) Higashi H, Barendregt JJ : Cost-effectiveness of total hip and knee replacements for the Australian population with osteoarthritis : discrete-event simulation model. PLoS One 6: e25403, 2011 (Epub 2011 Sep 23)